Trisha Shetty (Editor)

Keliximab

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Type
  
Whole antibody

Routes of administration
  
intravenous

CAS Number
  
174722-30-6

Target
  
CD4

ATC code
  
none

Source
  
Chimeric (primate/human)

Keliximab is a monoclonal antibody for the treatment of severe chronic asthma. It suppresses the immune reaction by binding to white blood cells via the protein CD4. The drug is a chimeric antibody from Macaca irus and Homo sapiens.

References

Keliximab Wikipedia